Aspirin

Pain, fever, and inflammation Acetylsalicylic acid (ASA), in the regular tablet form (immediate-release), is indicated to relieve pain, fever, and inflammation associated with many conditions, including the flu, the common cold, neck and back pain, dysmenorrhea, headache, tooth pain, sprains, fractures, myositis, neuralgia, synovitis, arthritis, bursitis, burns, and various injuries. It is also used for symptomatic pain relief after surgical and dental procedures . The extra strength formulation of acetylsalicylic acid is also indicated for the management migraine pain with photophobia (sensitivity to light) and phonophobia (sensitivity to sound). Other indications ASA is also indicated for various other purposes, due to its ability to inhibit platelet aggregation. These include: Reducing the risk of cardiovascular death in suspected cases of myocardial infarction (MI) . Reducing the risk of a first non-fatal myocardial infarction in patients, and for reducing the risk of morbidity and mortality in cases of unstable angina and in those who have had a prior myocardial infarction . For reducing the risk of transient ischemic attacks (TIA) and to prevent atherothrombotic cerebral infarction (in conjunction with other treatments) . For the prevention of thromboembolism after hip replacement surgery . For decreasing platelet to platelet adhesion following carotid endarterectomy, aiding in the prevention of transient ischemic attacks (TIA) . Used for patients undergoing hemodialysis with a silicone rubber arteriovenous cannula inserted to prevent thrombosis at the insertion site . Important note regarding use of the extended-release formulation In the setting of acute myocardial infarction, or before percutaneous interventions, the extended-release form of acetylsalicylic acid should not be used. Use immediate-release formulations in scenarios requiring rapid onset of action . The extended-release form is taken to decrease the incidence of mortality and myocardial infarction (MI) for individuals diagnosed with chronic coronary artery disease (CAD), including patients with previous myocardial infarction (MI) or unstable angina or with chronic stable angina. Additionally, the extended-release form is used to decrease the risk of death and recurrent episodes of stroke in patients with a history of stroke or TIA .

• Acute Coronary Syndrome (ACS)
• Anxiety
• Atherothrombotic cerebral infarction
• Cardiovascular Disease (CVD)
• Cardiovascular Events
• Cardiovascular Mortality
• Colorectal Adenomas
• Colorectal Cancer
• Common Cold
• Coronary artery reocclusion
• Death
• Dyspeptic signs and symptoms
• Fever
• Flu caused by Influenza
• Headache
• Heterozygous Familial Hypercholesterolemia (HeFH)
• Inflammation
• Juvenile Idiopathic Arthritis (JIA)
• Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
• Menstrual Pain
• Migraine
• Morbidity
• Mucocutaneous Lymph Node Syndrome
• Muscle Contraction
• Myalgia
• Myocardial Infarction
• Myocardial Infarction (MI), first occurrence
• Neuropathic Pain
• Pain
• Pain caused by Common Cold
• Pain caused by Rheumatism
• Pericarditis
• Polycythemia Vera (PV)
• Pre-Eclampsia
• Rheumatism
• Rheumatoid Arthritis
• Rhino Sinusitis
• Severe Pain
• Spondyloarthropathies
• Stroke
• Systemic Lupus Erythematosus
• Tension Headache
• Thromboembolism
• Thrombosis
• Toothache
• Transient Ischemic Attack
• Vascular Death
• Venous Thromboembolism
• Acute Inflammation
• Articular inflammation
• Atherothrombotic events
• Death caused by Myocardial Infarction
• Fever or influenza-like illness
• Moderate Pain
• Recurrent Ischemic Stroke